| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $375.6M | -1.9% |
| SG&A Expense | $97.0M | -31.8% |
| Operating Income | -$472.6M | +10.0% |
| Pre-tax Income | -$433.5M | +9.3% |
| Income Tax | $1.5M | — |
| Net Income | -$435.1M | +9.0% |
| EPS (Basic) | -$0.76 | +19.1% |
| EPS (Diluted) | -$0.76 | +19.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $230.5M | +63.6% |
| Short-term Investments | $740.3M | -3.8% |
| Current Assets | $981.6M | +6.4% |
| Total Assets | $1.31B | -1.1% |
| Current Liabilities | $61.5M | -5.1% |
| Total Liabilities | $139.2M | -15.4% |
| Stockholders' Equity | $1.17B | +1.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$242.5M | +11.7% |
| Capital Expenditures | $36.3M | -41.6% |
| Investing Cash Flow | $14.9M | -88.4% |
| Financing Cash Flow | $312.8M | +117.2% |
| Free Cash Flow | -$278.8M | +17.2% |